Cochlear (ASX:COH) said it expects further detail regarding the introduction of a 10% tariff on exports from Australia to the US in the US Customs and Border Protection Notice of Implementation, due to be published next week, according to a Thursday Australian bourse filing.
The firm imports its products under a chapter of the Harmonized Tariff Schedule of the United States, providing duty-free importation on a range of products into the US, including hearing implants.
Its shares fell over 1% in early trading on Thursday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。